Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-052974
Filing Date
2019-10-10
Accepted
2019-10-10 19:17:02
Documents
2
Period of Report
2019-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3953
2 POA DOCUMENT poa.txt EX-24.4_875820 3554
  Complete submission text file 0001209191-19-052974.txt   8921
Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER ST. WALTHAM MA 02451
Business Address
PEREZ ROBERT J (Reporting) CIK: 0001263230 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 191146868

Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)